Reply by Authors
J Urol
.
2021 Jun;205(6):1620-1621.
doi: 10.1097/JU.0000000000001633.03.
Epub 2021 Mar 18.
Authors
Justin T Matulay
1
,
Roger Li
2
,
Patrick J Hensley
3
,
Nathan A Brooks
3
,
Vikram M Narayan
4
,
H Barton Grossman
3
,
Neema Navai
3
,
Colin P N Dinney
3
,
Ashish M Kamat
3
5
Affiliations
1
Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
2
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.
3
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
4
Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
5
Urologic Oncology (Surgery), Wayne B. Duddlesten Professor of Cancer Research, University of Texas MD Anderson Cancer Center, Houston, Texas.
PMID:
33734859
DOI:
10.1097/JU.0000000000001633.03
No abstract available
Publication types
Comment